Home › Ulcerative Colitis › Louisiana › Lafayette
Ulcerative Colitis clinical trials in Lafayette, LA
5 studies for Ulcerative Colitis are looking for participants at sites in and around Lafayette (within about 30 miles). Open a study to see who can join and how to contact the study team.
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Care Access - New Iberia, New Iberia · 19 mi away
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Combined Gastro LLC, Lafayette
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Gastroenterology Clinic of Acadiana, Lafayette
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Care Access - New Iberia - Site Number: 8400031, New Iberia · 19 mi away
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Lafayette
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY24 studies
- Miami, FL22 studies
- Orlando, FL22 studies
- Houston, TX17 studies
- San Antonio, TX16 studies
- San Diego, CA15 studies
- Chicago, IL15 studies
- Tacoma, WA14 studies
- Colorado Springs, CO14 studies
- Tyler, TX13 studies
- Los Angeles, CA13 studies
- St. Louis, MO13 studies
Other studies in Lafayette
- Crohn's Disease7 studies
- Obesity4 studies
- Steatotic Liver Disease3 studies
- Bladder Cancer3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- Heart Failure3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.